Am J Psychiatry 156:1456-1458, September 1999
© 1999 American Psychiatric Association
Prediction of Level of Serotonin 2A Receptor Binding by Serotonin Receptor 2A Genetic Variation in Postmortem Brain Samples From Subjects Who Did or Did Not Commit Suicide
Gustavo Turecki, M.D., Ph.D.,
Richard Brière, Ph.D.,
Karen Dewar, Ph.D.,
Tonino Antonetti, M.Sc.,
Alain D. Lesage, M.D., M.Phil.,
Monique Séguin, Ph.D.,
Nadia Chawky, M.Sc.,
Claude Vanier, M.D.,
Martin Alda, M.D.,
Ridha Joober, M.D.,
Chawki Benkelfat, M.D., and
Guy A. Rouleau, M.D., Ph.D.
OBJECTIVE: Postmortem studies have indicated that suicide victims have greater serotonin receptor 2A (5-HTR2A) binding in prefrontal brain regions. However, there remains some controversy regarding the biological specificity of these findings. The authors hypothesized that the variance observed in brain 5-HTR2A binding is genetically mediated, at least in part. METHOD: Postmortem data from 56 subjects who had committed suicide and 126 normal comparison subjects were studied; brain tissue was available from 11 subjects who committed suicide and 11 comparison subjects. Homogenate binding assays were carried out with [3H]ketanserin. Variation at the 5-HTR2A gene (HTR2A) was investigated by means of two polymorphisms: T102C and A-1438G. RESULTS: 5-HTR2A binding was greater in the prefrontal cortex of the subjects who committed suicide. In addition, the findings suggest that HTR2A variation significantly affects 5-HTR2A binding. However, no interaction between suicidal behavior and this locus was observed. CONCLUSIONS: These results confirm previous reports of greater 5-HTR2A binding in subjects who committed suicide; they also provide preliminary evidence suggesting that the number of 5-HTR2A receptors is genetically mediated.
This article has been cited by other articles:
|
|
|
|
 
Z. Bhagwagar, R. Hinz, M. Taylor, S. Fancy, P. Cowen, and P. Grasby
Increased 5-HT2A Receptor Binding in Euthymic, Medication-Free Patients Recovered From Depression: A Positron Emission Study With [11C]MDL 100,907
Am J Psychiatry,
September 1, 2006;
163(9):
1580 - 1587.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. McCaffery, N. Frasure-Smith, M.-P. Dube, P. Theroux, G. A. Rouleau, Q. Duan, and F. Lesperance
Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin.
Psychosom Med,
March 1, 2006;
68(2):
187 - 200.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Meyer, S. Houle, S. Sagrati, A. Carella, D. F. Hussey, N. Ginovart, V. Goulding, J. Kennedy, and A. A. Wilson
Brain Serotonin Transporter Binding Potential Measured With Carbon 11-Labeled DASB Positron Emission Tomography: Effects of Major Depressive Episodes and Severity of Dysfunctional Attitudes
Arch Gen Psychiatry,
December 1, 2004;
61(12):
1271 - 1279.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Yoshida, H. Takahashi, H. Higuchi, M. Kamata, K.-i. Ito, K. Sato, S. Naito, T. Shimizu, K. Itoh, K. Inoue, et al.
Prediction of Antidepressant Response to Milnacipran by Norepinephrine Transporter Gene Polymorphisms
Am J Psychiatry,
September 1, 2004;
161(9):
1575 - 1580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Dube, R. F. Anda, V. J. Felitti, D. P. Chapman, D. F. Williamson, and W. H. Giles
Childhood Abuse, Household Dysfunction, and the Risk of Attempted Suicide Throughout the Life Span: Findings From the Adverse Childhood Experiences Study
JAMA,
December 26, 2001;
286(24):
3089 - 3096.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Zametkin, M. R. Alter, and T. Yemini
Suicide in Teenagers: Assessment, Management, and Prevention
JAMA,
December 26, 2001;
286(24):
3120 - 3125.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1999
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
